Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Assets Average (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Assets Average for 5 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 15.36% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 15.36% year-over-year, with the annual reading at $1.0 billion for FY2025, 43.08% up from the prior year.
  • Assets Average for Q4 2025 was $1.0 billion at Janux Therapeutics, down from $1.0 billion in the prior quarter.
  • The five-year high for Assets Average was $1.1 billion in Q1 2025, with the low at $347.2 million in Q2 2023.
  • Average Assets Average over 5 years is $592.8 million, with a median of $389.7 million recorded in 2021.
  • The sharpest move saw Assets Average decreased 7.89% in 2023, then skyrocketed 128.94% in 2024.
  • Over 5 years, Assets Average stood at $385.5 million in 2021, then decreased by 4.04% to $369.9 million in 2022, then rose by 3.72% to $383.6 million in 2023, then surged by 128.94% to $878.3 million in 2024, then increased by 15.36% to $1.0 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.0 billion, $1.0 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.